Clinical features and risk of relapses in children and adults with MOGAD.
Fiche publication
Date publication
septembre 2020
Journal
Annals of neurology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr DE SEZE Jérôme
Tous les auteurs :
Cobo-Calvo A, Ruiz A, Rollot F, Arrambide G, Deschamps R, Maillart E, Papeix C, Audoin B, Lépine AF, Maurey H, Zephir H, Biotti D, Ciron J, Durand-Dubief F, Collongues N, Ayrignac X, Labauge P, Pierre M, Thouvenot E, Bourre B, Montcuquet A, Cohen M, Horellou P, Tintoré M, De Seze J, Vukusic S, Deiva K, Marignier R,
Lien Pubmed
Résumé
The main objective was to compare clinical features, disease course, myelin oligodendrocyte glycoprotein (MOG)-antibody (Ab) dynamics, between children and adults with MOG-Ab-associated disease (MOGAD).
Mots clés
aquaporin-4 antibodies, disease course, myelin oligodendrocyte glycoprotein antibodies, neuromyelitis optica, prognosis
Référence
Ann. Neurol.. 2020 Sep 21;: